Purdue Pharma Offers Plan to End Sackler Control and Mounting Lawsuits

The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis.

from NYT > Health https://ift.tt/3bRljjG
via health&fitness